Healthcare -
Biotechnology - NASDAQ - US
$ 30.91
-1.4 %
$ 2.01 B
Market Cap
-10.37
P/E
KYMR - LONG-TERM INVESTMENTS
Long-term Investments KYMR - Kymera Therapeutics, Inc.
61.4 M
LAST VALUE
-29.95%
2 YEAR CAGR
214.71%
5 YEAR CAGR
0.00%
10 YEAR CAGR